Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6790837 | SCHERING | Ribavirin syrup formulations |
Apr, 2023
(2 months from now) | |
US6790837
(Pediatric) | SCHERING | Ribavirin syrup formulations |
Oct, 2023
(8 months from now) |
Market Authorisation Date: 29 July, 2003
Treatment: NA
Dosage: SOLUTION;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic